Sun Pharma Advanced Research Company — overview, financials & FAQs
Open a section to read the detail.
Sun Pharma Advanced Research Company (SPARC) share price is tracked live on this page, with the intraday move, day range, historical chart, financial results, shareholding pattern and technical levels for both NSE and BSE.
SPARC has been listed on the NSE since 18 July 2007 and trades under ISIN INE232I01014, with a face value of ₹1. It is classified by the NSE under Healthcare.
Prices update through the trading session. Figures on this page are for information only and are not a recommendation to buy or sell.
Sun Pharma Advanced Research Company key information
| Company | Sun Pharma Advanced Research Company |
|---|---|
| NSE symbol | SPARC |
| Sector | Healthcare |
| ISIN | INE232I01014 |
| Listed on NSE | 18 July 2007 |
| Face value | ₹1 |
| Series | EQ (rolling settlement, intraday allowed) |
| Exchanges | NSE and BSE |
| Previous close | ₹193.16 |
| 52-week range | ₹108.00 – ₹289.00 |
Sun Pharma Advanced Research Company Share Price Today
The live Sun Pharma Advanced Research Company (SPARC) share price above shows the last traded price, the change and percentage change for the session, and the day's open, high, low and previous close. Use the exchange toggle to switch between the NSE and BSE quote.
Sun Pharma Advanced Research Company Share Price Chart and History
The interactive chart plots SPARC across intraday, daily, weekly and monthly timeframes, so you can read the Sun Pharma Advanced Research Company share price history over any period and compare it against index or peer performance.
Sun Pharma Advanced Research Company Financials and Quarterly Results
The financials tab carries the quarterly and annual results for Sun Pharma Advanced Research Company — revenue, operating profit, net profit and earnings per share — alongside the balance sheet and cash-flow statements, so you can follow how each SPARC result compares with earlier periods.
Sun Pharma Advanced Research Company Shareholding Pattern
The shareholding pattern shows how Sun Pharma Advanced Research Company equity is split between promoters, foreign institutional investors, domestic institutions and public shareholders, with the quarter-on-quarter change in each holding as filed with the exchanges.
Sun Pharma Advanced Research Company Dividend, Bonus and Stock Split History
Corporate actions for SPARC — dividends declared and their ex-dates, along with any bonus issue, stock split or rights issue Sun Pharma Advanced Research Company has announced — are listed with the record dates the exchanges published.
Sun Pharma Advanced Research Company 52-Week High and Low
Over the last year Sun Pharma Advanced Research Company (SPARC) has traded between ₹108.00 and ₹289.00. The 52-week range is the simplest read on where the current price sits against its own recent history.
Sun Pharma Advanced Research Company Technical Analysis and Pivot Levels
Technical levels for SPARC include moving averages, RSI, MACD and classic, Fibonacci and Camarilla pivot tables, plus the 52-week high and low, to help frame support and resistance around the current Sun Pharma Advanced Research Company share price.
Healthcare sector peers
- Strides Pharma Science Limited
- Solara Active Pharma Sciences Limited
- Sun Pharmaceutical Industries Limited
- SMS Pharmaceuticals Limited
- Supreme Holdings & Hospitality (India) Limited
- Shilpa Medicare Limited
- Supriya Lifescience Limited
- Senores Pharmaceuticals Limited
- Suraksha Diagnostic Limited
- Sanofi Consumer Healthcare India Limited
- Suven Life Sciences Limited
- Sakar Healthcare Limited
Browse more stocks
- Speciality Restaurants Limited
- Spandana Sphoorty Financial Limited
- Spectrum Electrical Industries Limited
- S. P. Apparels Limited
- Spencer's Retail Limited
- South West Pinnacle Exploration Limited
- Southern Petrochemicals Industries Corporation Limited
- The South Indian Bank Limited
- SPL Industries Limited
- Savita Oil Technologies Limited
- Supreme Petrochem Limited
- Sonata Software Limited
Tools for trading SPARC
Sun Pharma Advanced Research Company share price — frequently asked questions
What is the Sun Pharma Advanced Research Company share price today?
The live Sun Pharma Advanced Research Company (SPARC) price is shown at the top of this page, together with the day's change, open, high, low and previous close for both NSE and BSE. It updates through the trading session.
What is the NSE symbol and ISIN for Sun Pharma Advanced Research Company?
Sun Pharma Advanced Research Company trades on the NSE under the symbol SPARC, with ISIN INE232I01014 in the EQ series.
When was Sun Pharma Advanced Research Company listed on the stock exchange?
Sun Pharma Advanced Research Company (SPARC) has been listed on the National Stock Exchange since 18 July 2007. Its shares carry a face value of ₹1.
Where can I see Sun Pharma Advanced Research Company quarterly results and financials?
The financials section on this page carries Sun Pharma Advanced Research Company's quarterly and annual results, balance sheet and cash-flow statements, so you can compare each SPARC reporting period against the last.
Does Sun Pharma Advanced Research Company pay a dividend?
Any dividend, bonus issue or stock split Sun Pharma Advanced Research Company has declared appears in the corporate actions section on this page, with the ex-date and record date as published by the exchanges.
What is the Sun Pharma Advanced Research Company shareholding pattern?
The shareholding section breaks SPARC down by promoter, foreign institutional, domestic institutional and public holding, with the change from the previous quarter.
Which sector does Sun Pharma Advanced Research Company belong to?
The NSE classifies Sun Pharma Advanced Research Company under Healthcare. You can compare it against other Healthcare stocks from the sector peers listed on this page.
How do I buy Sun Pharma Advanced Research Company shares?
You need a trading and demat account to buy SPARC on the NSE or BSE. Once your account is active you can place a buy or sell order from this page. Nothing here is a recommendation — please make your own assessment.